Cancer therapeutics biotech BeyondSpring scored $54.3 million in a combination IPO and private placement. The total falls well short of its initial $100 million target and relied almost exclusively on the placement for the bulk of its cut-price raise.
Genzyme's former VP becomes Editas' CMO, SynteractHCR makes three high-profile appointments, and Michael Rogers steps down as Acorda’s CFO. Plus more hirings, firings and retirings throughout the industry.
Welcome to this week's Chutes and Ladders, our roundup of hirings and retirings throughout the industry. In this edition, James McArthur was selected to lead Imara, a new play by the biotech accelerator Cydan.